ARCHIVES

MSK Starts Ovarian Cancer Program

This article is from The Cancer Letter archive.

Vol. 12 No. 45 | November 21, 1986

Download PDF Visit The Full Archive

Related Articles

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

NCAB Approves Concept Of Four Contract Program

May 29, 1981

Capizzi Succeeds Spurr as Director Of Bowman Gray Cancer Center

September 10, 1982

Peer Review changes Urged By NIH Team Include Appeals

April 8, 1977

NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial

March 8, 1991

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

August 13, 2004